Connect with Cryoport

Subscribe by Email

Your email:

Browse by Category

Cryoport News

Current Articles | RSS Feed RSS Feed

COMBIMATRIX SELECTS CRYOPORT AS LOGISTICS PARTNER FOR THE DISTRIBUTION OF ITS NEW GENETIC SCREENING SERVICE

  
  
  

IRVINE, California, and LAKE FOREST, California, March XX, 2015 – CombiMatrix Corporation (NASDAQ: CBMX) and Cryoport, Inc. (OTCBB: CYRX), today announced CombiMatrix has selected Cryoport as its cryogenic logistics partner for the distribution of its new CombiPGS™ genetic screening test.

Cryoport Introduces New Tamper-Proof Lock on its Cryoport Express® Shippers for Animal Husbandry

  
  
  

Lake Forest, CA, March 18, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company introduced a new tamper-proof lock on its Cryoport Express® Shippers for exclusive use in the global animal husbandry market.

Cryoport Co-Sponsors the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day

  
  
  

Lake Forest, CA, March 11, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that it is co-sponsoring the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day, to be held March 25, 2015 at the Metropolitan Club in New York City.

Broekman Logistics to Support Expansion of Cryoport’s Growing Client Base in Asia

  
  
  

LAKE FOREST, CA – March 5, 2015 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that Broekman Logistics will support Cyroport’s Operations Center in Singapore, responding to Cryoport’s rapidly expanding client base in Asia. Broekman currently supports Cryoport’s European Operations Center, ensuring a seamless faciliation of Cryoport’s solutions for global life sciences clients.

Cryoport Inc. Expands Support of Fred Hutchinson Cancer Research Center’s Clinical Research Division

  
  
  

Lake Forest, CA, March 3, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the expansion of its relationship with Fred Hutchinson Cancer Research Centers’ (“Fred Hutch”) Clinical Research Division with the inclusion of additional labs to be supported by Cryoport’s validated cryogenic logistics solutions for its cell-based therapies.

Cryoport Provides Logistics Solution and Services for Kite Pharma’s Lead Clinical Program in Cancer Immunotherapy

  
  
  

Lake Forest, CA, February 24, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company’s best-in-class logistics solution is supporting Kite Pharma’s (“Kite”) clinical program for their lead product candidate, KTE-C19, a CAR-T cell therapy for non-Hodgkin’s lymphoma (“NHL”).

Cryoport and Sanaria Expand Logistics Partnership Supporting Malaria Vaccines

  
  
  

Lake Forest, CA, February 23, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company is enhancing its cryogenic logistics support of its Sanaria partnership, which includes Sanaria’s production of malaria vaccine as well as its research and development efforts.

Cryoport Launches New Logistics Service Supporting Facility Relocation of Cryogenically Frozen Sample Collections

  
  
  

Lake Forest, CA, February 17, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the launch of a new logistics service supporting complete facility relocation of critical cryogenically frozen sample collections.

Cryoport Initiates Support of the Growing In-Vitro Fertilization Market in Nepal

  
  
  

Lake Forest, CA, February 10, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it has initiated support of the growing in-vitro fertilization (“IVF”) market in Nepal.

Cryoport Reports Record Results; Grows Revenue by 50% for the First Nine Months of Fiscal 2015

  
  
  

LAKE FOREST, CA – February 5, 2015 — Cryoport, Inc. (CYRX) today announced financial results for its fiscal third quarter and nine months ended December 31, 2014.

All Posts